May 2008
Three IM Antipsychotics
New intramuscular (IM) formulations of second-generation antipsychotics appear comparable and possibly superior in efficacy and safety to older agents, but are more expensive.
Baclofen for Alcohol Dependency with Liver Cirrhosis
Baclofen (Lioresal and others) shows efficacy in treating alcohol dependency with no adverse hepatic effects.
Antipsychotics to Treat Aggression in Patients with Intellectual Disability
A double-blind study finds little evidence to support the use of antipsychotics to treat aggression in patients with intellectual disability.
In Brief
Desvenlafaxine Approved for Depression; Olanzapine LAI Not Approved for Schizophrenia
Depression Infrequently Treated
Many patients with depression worldwide do not receive effective care.
Clozapine Plus Aripiprazole
Aripiprazole (Abilify) may be beneficial for patients with schizophrenia who respond only partially to clozapine (Clozaril and others).
Three IM Antipsychotics
May 2008
Three second-generation antipsychotics are now available in a rapid-acting intramuscular (IM) formulation: ziprasidone (Geodon), olanzapine (Zyprexa), and aripiprazole (Abilify). Their intended use is for agitation, typically in the face of a psychotic disorder such as schizophrenia or bipolar…
To view the rest of this article, please:
For current
BTP subscribers
Purchase access
to all articles
Purchase this article
for $3 (USD)